Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-09

Clinical Trial Update: Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use [Phase 2]

View source ↗

Summary

Phase 2 trial comparing purified Vero Rabies Vaccine, serum-free, with human diploid cell vaccine for pre-exposure use in rabies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Diploid Cell Vaccine (Rabies vaccine, human diploid cell)
  • Purified Vero Rabies Vaccine Serum Free (Purified Vero Rabies Vaccine Serum Free)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Rabies | Phase 2 | Status: COMPLETED